
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TWST market cap is 2.12B. The company's latest EPS is USD -3.4836 and P/E is -10.14.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 75.3M | 81.46M | 84.71M | 88.71M | 92.79M |
Operating Income | -48.89M | -88.92M | -36.04M | -34.64M | -41.56M |
Net Income | -45.49M | -85.57M | -34.66M | -31.59M | -39.33M |
Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 90.1M | 132.87M | 217.81M | 251.02M | 312.97M |
Operating Income | -139.88M | -152.73M | -234.78M | -217.16M | -220.83M |
Net Income | -139.73M | -152.1M | -217.86M | -204.62M | -208.73M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 702.85M | 638.12M | 614.32M | 608.58M | 595.62M |
Total Liabilities | 142.72M | 146.98M | 141.63M | 152.64M | 155.51M |
Total Equity | 560.13M | 491.14M | 472.69M | 455.94M | 440.11M |
Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 398.88M | 702.1M | 961.38M | 776.4M | 614.32M |
Total Liabilities | 62.62M | 121.28M | 171.99M | 152.97M | 141.63M |
Total Equity | 336.26M | 580.82M | 789.39M | 623.43M | 472.69M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -42.4M | -48.77M | -64.09M | -21.43M | -34.41M |
Investing | -1.08M | -1.79M | -3.07M | -1.54M | -2.96M |
Financing | 355k | 3.26M | 6.89M | 17.94M | 21.14M |
Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -142.26M | -112.24M | -124.39M | -142.47M | -64.09M |
Investing | -114.65M | 156.16M | -232.93M | 50.61M | -3.07M |
Financing | 303.73M | 329.18M | 270.53M | 911k | 6.89M |
Market Cap | 2.12B |
Price to Earnings Ratio | -10.14 |
Price to Sales Ratio | 6.76 |
Price to Cash Ratio | 9.35 |
Price to Book Ratio | 4.48 |
Dividend Yield | - |
Shares Outstanding | 59.92M |
Average Volume (1 week) | 1.05M |
Average Volume (1 Month) | 1.19M |
52 Week Change | -30.68% |
52 Week High | 60.90 |
52 Week Low | 27.12 |
Spread (Intraday) | 2.36 (6.46%) |
Company Name | Twist Bioscience Corporation |
Address |
3500 south dupont highway dover, delaware 19901 |
Website | https://www.twistbioscience.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions